Factor XIa (FXIa) reagents for next-generation anticoagulant research.
Aniara supplies Factor XIa and related chromogenic tools used to study the contact pathway and to develop FXI/FXIa inhibitors — a leading low-bleeding-risk antithrombotic drug class (e.g., asundexian and milvexian, in development). Investigational drugs named are scientific context and are not Aniara products. For research use.
Download Factor XIa flyers below.
